Siret Kivistik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Siret Kivistik has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Eija Metsälä
Department of Nursing Science, Faculty of Medicine University of Turku Turku Finland
2 shared publications - Aileen Duffton
The Beatson West of Scotland Cancer Centre, Glasgow, UK
1 shared publication - B. Strom
Western Norway University of Applied Sciences (HVL), Norway
1 shared publication Bergliot Strom
Faculty of Health and Social Science, Western Norway University of Applied Sciences, Bergen, Norway
1 shared publicationCarmen Monge-Montero
Youth Cancer Europe, 400372 Cluj-Napoca, Romania
1 shared publication- Cynthia L. Eccles
Division of Cancer Sciences, University of Manchester, Manchester M20 4BX, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (5) , 263
Educational Needs Regarding Mental Health of Professionals Working with Young Adults with Cancer: A European Survey
Worldwide, an increase in cancer diagnosis has been identified, especially in people under 50 years and in young adults (YAs, age group 18–39 years)
- 30 April 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (5) , 263
Open AccessEducational Needs Regarding Mental Health of Professionals Working with Young Adults with Cancer: A European Survey
Worldwide, an increase in cancer diagnosis has been identified, especially in people under 50 years and in young adults (YAs, age group 18–39 years)
- Open Access
- 24 April 2026
- Published by Elsevier in SSRN Electronic Journal
Radiation therapist research engagement and culture: findings from the ESTRO Radiation TherapisT workshop
Background and Purpose: Despite widespread recognition of the value of research among radiation therapists (RTTs), sustained engagement remains low across international settings. This study aimed to explore RTT perspectives on research engagement, characterise the cultural conditions shaping participation, and generate structured recommendations for strengthening RTT research culture.Materials and Methods: A qualitative, workshop-based study was conducted through the ESTRO RTT workshop series. A sixteen-member Research Engagement Expert Reference Group (RE-ERG), drawn from ten countries, participated in two virtual sessions. The cultural web framework was applied in Workshop 1 to map research culture across six organisational elements. In Workshop 2, participants validated findings and developed recommendations structured around three strategic pillars: Preserve, Adapt, and Innovate (PAI). Real-time polling and recorded transcripts were analysed using deductive thematic analysis informed by the cultural web framework.Results: Two cross-cutting tensions emerged: a persistent recognition-to-practice gap in which strong endorsement of research coexisted with structural barriers to participation, and a reliance on individual commitment rather than systemic support, with research frequently described as “hidden work” conducted outside rostered hours. 15/16 participants (94%) agreed that RTTs could make a significant contribution to research. The Preserve pillar identified five foundational strengths including collaboration, mentorship, visibility, organisational support, and patient-focused research. The Adapt pillar generated recommendations addressing education, governance simplification, career pathway clarity, and protected time. The Innovate pillar emphasised research champion roles, graduated fellowship schemes, digital collaboration platforms, and embedding research within departmental objectives and international networks.Conclusion: RTTs collectively articulate a clear and actionable vision for research culture development, yet realising it requires coordinated action from departments, national professional bodies, and international organisations. Applying the cultural web framework alongside the PAI pillars produced practitioner-grounded recommendations that move beyond barrier identification towards infrastructures that make research participation an expected and enabled dimension of RTT professional practice.
- 24 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessRadiation therapist research engagement and culture: findings from the ESTRO Radiation TherapisT workshop
Background and Purpose: Despite widespread recognition of the value of research among radiation therapists (RTTs), sustained engagement remains low across international settings. This study aimed to explore RTT perspectives on research engagement, characterise the cultural conditions shaping participation, and generate structured recommendations for strengthening RTT research culture.Materials and Methods: A qualitative, workshop-based study was conducted through the ESTRO RTT workshop series. A sixteen-member Research Engagement Expert Reference Group (RE-ERG), drawn from ten countries, participated in two virtual sessions. The cultural web framework was applied in Workshop 1 to map research culture across six organisational elements. In Workshop 2, participants validated findings and developed recommendations structured around three strategic pillars: Preserve, Adapt, and Innovate (PAI). Real-time polling and recorded transcripts were analysed using deductive thematic analysis informed by the cultural web framework.Results: Two cross-cutting tensions emerged: a persistent recognition-to-practice gap in which strong endorsement of research coexisted with structural barriers to participation, and a reliance on individual commitment rather than systemic support, with research frequently described as “hidden work” conducted outside rostered hours. 15/16 participants (94%) agreed that RTTs could make a significant contribution to research. The Preserve pillar identified five foundational strengths including collaboration, mentorship, visibility, organisational support, and patient-focused research. The Adapt pillar generated recommendations addressing education, governance simplification, career pathway clarity, and protected time. The Innovate pillar emphasised research champion roles, graduated fellowship schemes, digital collaboration platforms, and embedding research within departmental objectives and international networks.Conclusion: RTTs collectively articulate a clear and actionable vision for research culture development, yet realising it requires coordinated action from departments, national professional bodies, and international organisations. Applying the cultural web framework alongside the PAI pillars produced practitioner-grounded recommendations that move beyond barrier identification towards infrastructures that make research participation an expected and enabled dimension of RTT professional practice.
- Open Access
- 20 April 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 34, 100312
Perceptions, educational expectations and knowledge gaps of patients with non-metastatic breast cancer regarding radiotherapy: Integrative review
- 20 April 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 34, 100312
Open AccessPerceptions, educational expectations and knowledge gaps of patients with non-metastatic breast cancer regarding radiotherapy: Integrative review
- 1 July 2022
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 18 (3) , 222-228
The Factors for Success and Lack of Success in the Breast Cancer Patient Care Pathway: A Qualitative Study From the Health Care Staff Perspective
To produce information about factors related to successful and unsuccessful breast cancer care pathways from the health care staff perspective. An electronic qualitative survey was used to collect data simultaneously from hospitals located in four different countries, focusing on four professional groups: diagnostic radiographers; radiation therapists; breast cancer nurses; and biomedical laboratory scientists (n = 23). The hospitals participating in the study treat breast cancer patients and research permits were applied from all of them. Data was analysed by deductive thematic analysis. At the core of a successful breast cancer care pathway is the right content and timely information provided to the patient at the pace the patient is able to adopt. This is especially highlighted at the beginning of the treatment process. In regards to diagnostic services, rigorous execution of mammography, sampling techniques and analyses were seen as important. Staff also valued the importance of aftercare and follow-up, and highlighted the fact that the patient should be given a chance to keep in close contact with care and treatment staff, even after their active treatment process has finished. Health care staff recognized the same success factors for optimal breast cancer care and treatment pathways as patients reported in previous studies, yet more emphasis was put on patient characteristics and the technical performance features of the process. Both patient and staff viewpoints should be taken into account in planning breast cancer care pathways.
- 1 July 2022
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 18 (3) , 222-228
The Factors for Success and Lack of Success in the Breast Cancer Patient Care Pathway: A Qualitative Study From the Health Care Staff Perspective
To produce information about factors related to successful and unsuccessful breast cancer care pathways from the health care staff perspective. An electronic qualitative survey was used to collect data simultaneously from hospitals located in four different countries, focusing on four professional groups: diagnostic radiographers; radiation therapists; breast cancer nurses; and biomedical laboratory scientists (n = 23). The hospitals participating in the study treat breast cancer patients and research permits were applied from all of them. Data was analysed by deductive thematic analysis. At the core of a successful breast cancer care pathway is the right content and timely information provided to the patient at the pace the patient is able to adopt. This is especially highlighted at the beginning of the treatment process. In regards to diagnostic services, rigorous execution of mammography, sampling techniques and analyses were seen as important. Staff also valued the importance of aftercare and follow-up, and highlighted the fact that the patient should be given a chance to keep in close contact with care and treatment staff, even after their active treatment process has finished. Health care staff recognized the same success factors for optimal breast cancer care and treatment pathways as patients reported in previous studies, yet more emphasis was put on patient characteristics and the technical performance features of the process. Both patient and staff viewpoints should be taken into account in planning breast cancer care pathways.
- Open Access
- 20 June 2022
- Published by Elsevier in Radiography
- Vol. 28 (3) , 697-703
Breast cancer patients’ experiences on their individual care pathway: A qualitative study
- 20 June 2022
- Published by Elsevier in Radiography
- Vol. 28 (3) , 697-703
Open AccessBreast cancer patients’ experiences on their individual care pathway: A qualitative study
- Open Access
- 1 December 2018
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 8, 13-14
Case report: The Estonian experience of the IAEA/ESTRO “Train the Trainers” project
- 1 December 2018
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 8, 13-14
Open AccessCase report: The Estonian experience of the IAEA/ESTRO “Train the Trainers” project
- 30 September 2013
- Published by Hindawi Limited in European Journal of Cancer Care
- Vol. 23 (2) , 249-254
Complementary medicine use among cancer patients receiving radiotherapy and chemotherapy: methods, sources of information and the need for counselling
Complementary medicine (CM) use is common among cancer patients. However, little is known about CM products that are utilised during radiotherapy and/or chemotherapy. Out of 62 cancer patients who completed a specialised survey, 35 (56%) consumed some type of CM during active anti-cancer therapy. Cancer patients reported the use of herbal teas (52%), vitamins and other dietary supplements (45%), vegetables and juices (39%), special diets (19%), herbal medicines, including Chinese medicines (19%) and 'immunomodulators' (3%). Most of patients (86%) consumed CM products every day. However, nearly 47% of CM users did not admit this to their oncologists. Majority of CM users (85%) were convinced that supplementary products increase the efficacy of standard anti-cancer therapy and prolong their survival. Information about CM was mainly obtained through internet sources (36%), books and brochures (25%). Although most CM users (82%) trusted the received information, 73% of them admitted that additional information about CM methods would be necessary. Patients would like to receive additional information through a specialised consultation (60%), but also from brochures (44%) and the internet (20%). Adequate counselling of patients is of paramount importance since some CM methods may cause significant side effects and decrease the efficacy of radiotherapy and/or chemotherapy.
- 30 September 2013
- Published by Hindawi Limited in European Journal of Cancer Care
- Vol. 23 (2) , 249-254
Complementary medicine use among cancer patients receiving radiotherapy and chemotherapy: methods, sources of information and the need for counselling
Complementary medicine (CM) use is common among cancer patients. However, little is known about CM products that are utilised during radiotherapy and/or chemotherapy. Out of 62 cancer patients who completed a specialised survey, 35 (56%) consumed some type of CM during active anti-cancer therapy. Cancer patients reported the use of herbal teas (52%), vitamins and other dietary supplements (45%), vegetables and juices (39%), special diets (19%), herbal medicines, including Chinese medicines (19%) and 'immunomodulators' (3%). Most of patients (86%) consumed CM products every day. However, nearly 47% of CM users did not admit this to their oncologists. Majority of CM users (85%) were convinced that supplementary products increase the efficacy of standard anti-cancer therapy and prolong their survival. Information about CM was mainly obtained through internet sources (36%), books and brochures (25%). Although most CM users (82%) trusted the received information, 73% of them admitted that additional information about CM methods would be necessary. Patients would like to receive additional information through a specialised consultation (60%), but also from brochures (44%) and the internet (20%). Adequate counselling of patients is of paramount importance since some CM methods may cause significant side effects and decrease the efficacy of radiotherapy and/or chemotherapy.